Table 2 Association with clinicopathological findings

From: Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes

 

Months after first sample

Patient

0

1

2

3

4

5

6

7

8

9

10

11

12

13

No. 11FS 3Ex 10

Gly

Gly

Val

NA

Val

Val

Val

Val

←Ki-ras status in plasma

     
 

2654

2706

5288

>104

8077

NA

>104

 

←CA 19-9 level in serum (U ml−1)

     
 

GFF

GFF

Tax

Tax

Tax

Tax

Tax

Tax

←(Chemo-) therapy

     
 

NC

 

PD

     

←Imaging

     

No. 13FS 0Ex 7

Gly

NA

Gly

NA

Gly

Gly

Gly

       
 

6879

NA

698

654

2254

>104

>104

       
 

Gem

Gem

Gem

Gem

Gem

Gem

OFF

       
    

PR

 

PD

        

No. 16FS 22Ex 35

Gly

NA

Gly

NA

Gly

NA

Gly

Gly

Gly

Gly

Gly

NA

Gly

Gly

 

109

62

43

NA

45

90

NA

191

340

426

1948

NA

4216

NA

 

OFF

OFF

OFF

OFF

OFF

OFF

OFF

OFF

OFF

OFF

OFF

OFF

Gem

Gem

    

NC

   

NC

    

PD

 

No. 29FS 2Ex 5

Gly

Gly

Gly

NA

          
 

1

NA

9

32

          
 

Gem

OFF

 

OFF

          
 

PD

  

PD

          

No. 34FS 1Ex 8

Gly

NA

Gly

Gly

Mut

Mut

Mut

       
 

5916

2291

4169

>104

>104

>105

NA

       
 

Gem

Gem

Gem

Gem

Gem

OFF

OFF

       
   

PR

 

PD

         

No. 37FS 11Ex 23

Gly

NA

Gly

NA

Gly

Gly

Gly

Gly

Gly

Gly

Gly

   
 

7

NA

13

NA

28

37

NA

41

50

52

56

   
 

Tax

Tax

Tax

Tax

Tax

Tax

Tax

Tax

Tax

Tax

Tax

   

No. 38FS 1Ex 5

Gly

Gly

Gly

Gly

          
 

>106

>106

NA

>106

          
 

Gem

Gem

OFF

OFF

          
   

PD

           

No. 39FS 82Ex 83

Gly

Val

            
 

>104

>104

            
 

Gem

Gem

            
 

PD

             

No. 40FS 31Ex 43

Gly

NA

NA

Gly

NA

Gly

Gly

Gly

Gly

Gly

Gly

NA

Gly

 
 

NA

NA

309

NA

NA

464

NA

179

NA

NA

218

NA

251

 
 

Gem

Gem

Gem

Gem

OFF

   

Tax

Tax

Tax

   
    

PD

          

No. 43FS 1Ex 14

Val

NA

NA

Val

Val

Val

Val

Val

Val

Val

Val

NA

NA

 
 

677

NA

434

1365

2116

5231

883

446

544

1506

>104

>104

  
 

GFF

GFF

GFF

GFF

GFF

Tax

Tax

Tax

Tax

Tax

Tax

   
    

PD

    

PR

     
  1. FS=time of 1st collected sample after diagnosis (in months); Ex=death in months after collection of the 1st sample; NA=no data available; Gly=glycine (wild type); Val=valine (mutation); Mut=mutation different from valine; GFF=gemcitabine+5-fluorouracil+folinic acid; Gem=gemcitabine mono; Tax=taxol; OFF=oxaliplatin+5-fluorouracil+folinic acid; NC=no change; PD=progressive disease; PR=partial regression.